GE Healthcare Partners With UE Lifesciences to Scale-Up Early Detection of Breast Cancer in 25 Countries

UE LifeSciences Inc., a USA-India based med-tech startup today announced a pivotal distribution partnership with GE Healthcare to commercialize iBreastExam (iBE) in 25+ countries across South Asia, South-East Asia and Africa. The partnership brings together UE LifeSciences’ skills to design and develop mobile health innovations, and GE Healthcare’s sales, marketing and distribution expertise in these markets to enable early detection of breast cancer in the developing world.

“Large scale access to early detection is the key to lowering the burden of breast cancer in the developing world”, says Mihir Shah, Founder and CEO, UE LifeSciences. “Affordable, accurate and easy to use primary-care tool like iBreastExam is one aspect of the solution. There is also a need for experienced teams across geographies that can seamlessly connect the care pathway – from primary care and women’s health to radiology, diagnostics and oncology. Our partnership with GE Healthcare will combine the power of innovation and scale to fight breast cancer in a whole new way.”

Commenting on the partnership, Terri Bresenham, President and CEO, GE Healthcare Sustainable Healthcare Solutions said, “We are delighted to welcome UE Lifesciences as a partner in our efforts to improving healthcare outcomes for the world’s developing economies. GE …

To read more subscribe
Show More

Related Articles

Leave a Reply